JP2005530852A5 - - Google Patents

Download PDF

Info

Publication number
JP2005530852A5
JP2005530852A5 JP2004517277A JP2004517277A JP2005530852A5 JP 2005530852 A5 JP2005530852 A5 JP 2005530852A5 JP 2004517277 A JP2004517277 A JP 2004517277A JP 2004517277 A JP2004517277 A JP 2004517277A JP 2005530852 A5 JP2005530852 A5 JP 2005530852A5
Authority
JP
Japan
Prior art keywords
hydrogen
lower alkyl
biphenyl
amino
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004517277A
Other languages
English (en)
Japanese (ja)
Other versions
JP3852708B2 (ja
JP2005530852A (ja
Filing date
Publication date
Priority claimed from AUPS3241A external-priority patent/AUPS324102A0/en
Priority claimed from AU2002953604A external-priority patent/AU2002953604A0/en
Application filed filed Critical
Priority claimed from PCT/JP2003/008061 external-priority patent/WO2004002939A2/en
Publication of JP2005530852A publication Critical patent/JP2005530852A/ja
Publication of JP2005530852A5 publication Critical patent/JP2005530852A5/ja
Application granted granted Critical
Publication of JP3852708B2 publication Critical patent/JP3852708B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004517277A 2002-06-27 2003-06-25 アミノアルコール誘導体 Expired - Fee Related JP3852708B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPS3241A AUPS324102A0 (en) 2002-06-27 2002-06-27 Aminoalcohol derivatives
AU2002953604A AU2002953604A0 (en) 2002-12-30 2002-12-30 Aminoalcohol derivatives
PCT/JP2003/008061 WO2004002939A2 (en) 2002-06-27 2003-06-25 Aminoalcohol derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2006195098A Division JP4587127B2 (ja) 2002-06-27 2006-07-18 アミノアルコール誘導体

Publications (3)

Publication Number Publication Date
JP2005530852A JP2005530852A (ja) 2005-10-13
JP2005530852A5 true JP2005530852A5 (https=) 2006-04-13
JP3852708B2 JP3852708B2 (ja) 2006-12-06

Family

ID=30001235

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004517277A Expired - Fee Related JP3852708B2 (ja) 2002-06-27 2003-06-25 アミノアルコール誘導体
JP2006195098A Expired - Fee Related JP4587127B2 (ja) 2002-06-27 2006-07-18 アミノアルコール誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2006195098A Expired - Fee Related JP4587127B2 (ja) 2002-06-27 2006-07-18 アミノアルコール誘導体

Country Status (14)

Country Link
US (2) US7037938B2 (https=)
EP (1) EP1546086A2 (https=)
JP (2) JP3852708B2 (https=)
KR (1) KR100693367B1 (https=)
AR (1) AR040473A1 (https=)
BR (1) BR0311788A (https=)
CA (1) CA2492065A1 (https=)
MX (1) MXPA04012783A (https=)
NO (1) NO20050470L (https=)
NZ (1) NZ537206A (https=)
PL (1) PL375195A1 (https=)
RU (1) RU2319698C2 (https=)
TW (1) TWI331137B (https=)
WO (1) WO2004002939A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101071748B1 (ko) * 2003-12-23 2011-10-11 아스텔라스세이야쿠 가부시키가이샤 아미노알콜 유도체
TW200531692A (en) 2004-01-12 2005-10-01 Theravance Inc Aryl aniline derivatives as β2 adrenergic receptor agonists
WO2006014704A1 (en) 2004-07-21 2006-02-09 Theravance, Inc. DIARYL ETHER β2 ADRENERGIC RECEPTOR AGONISTS
EP1786762A2 (en) * 2004-09-10 2007-05-23 Theravance, Inc. Amidine substituted aryl aniline compounds
US7928264B2 (en) * 2004-09-21 2011-04-19 Astellas Pharma Inc. Aminoalcohol derivatives
AU2005285812B2 (en) * 2004-09-21 2011-02-24 Astellas Pharma Inc. Aminoalcohol derivatives
FR2880885B1 (fr) * 2005-01-14 2009-01-30 Merck Sante Soc Par Actions Si Derives d'acide phenylbenzoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
DE602006007810D1 (de) * 2006-04-21 2009-08-27 Cellzome Ltd Substituierte Biphenylcarbonsäuren und deren Derivate
EP2035372A1 (en) * 2006-06-29 2009-03-18 Arena Pharmaceuticals, Inc. Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
JO3598B1 (ar) 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
ES2302447B1 (es) * 2006-10-20 2009-06-12 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
AU2009231967B2 (en) * 2008-04-04 2013-02-07 Merck Sharp & Dohme Corp. Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
TW201000107A (en) * 2008-04-09 2010-01-01 Infinity Pharmaceuticals Inc Inhibitors of fatty acid amide hydrolase
WO2010118155A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
CA2757622A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
MX361692B (es) 2010-02-03 2018-12-13 Infinity Pharmaceuticals Inc Inhibidores de amida hidrolasa de ácido graso.
FR2961204A1 (fr) * 2010-06-11 2011-12-16 Centre Nat Rech Scient Procede de substitution nucleophile aromatique a partir d'acides difluorobenzoiques
EP2558458B1 (de) 2010-04-16 2017-09-06 Bayer Intellectual Property GmbH Neue heterocyclische verbindungen als schädlingsbekämpfungsmittel
AR083431A1 (es) 2010-06-28 2013-02-27 Bayer Cropscience Ag Compuestos heterociclicos como pesticidas
DK3362462T3 (da) 2015-10-12 2021-10-11 Advanced Cell Diagnostics Inc In situ-detektion af nukleotidvarianter i prøver med højt støjniveau, og sammensætninger og fremgangsmåder relateret dertil
KR20180125960A (ko) 2016-03-15 2018-11-26 바이엘 크롭사이언스 악티엔게젤샤프트 동물 해충을 방제하기 위한 치환된 술포닐 아미드
TW201822637A (zh) 2016-11-07 2018-07-01 德商拜耳廠股份有限公司 用於控制動物害蟲的經取代磺醯胺類

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3718638A1 (de) * 1987-06-04 1988-12-22 Thomae Gmbh Dr K Neue phenylethanolamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL112778A0 (en) * 1994-03-04 1995-05-26 Merck & Co Inc Substituted heterocycles, their preparation and pharmaceutical compositions containing them
GB2305665A (en) * 1995-09-26 1997-04-16 Merck & Co Inc Selective ß3 agonists for the treatment of diabetes aand obesity
CZ20031012A3 (en) * 2000-10-20 2004-04-14 Pfizer Products Inc. Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
TWI249515B (en) * 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
AU2002952839A0 (en) 2002-11-21 2002-12-05 Fujisawa Pharmaceutical Co., Ltd. Aminoalcohol derivatives
KR101071748B1 (ko) 2003-12-23 2011-10-11 아스텔라스세이야쿠 가부시키가이샤 아미노알콜 유도체

Similar Documents

Publication Publication Date Title
JP2005530852A5 (https=)
RU2005101876A (ru) Производные аминоспиртов
JP2005526011A5 (https=)
JP2004516314A5 (https=)
RU2005100836A (ru) Производные пептидов, содержащие тиазепиновую группу, для лечения гиперлипемических состояний
JP2007533722A5 (https=)
JP2002540208A5 (https=)
JP2013533228A5 (https=)
RU2005123802A (ru) Производные адамантана, способы их получения и содержащие их фармацевтические композиции
JP2007510619A5 (https=)
BR0214199A (pt) Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração
JP2002520316A5 (https=)
JP2010522710A5 (https=)
JP2005536503A5 (https=)
JP2005511697A5 (https=)
RU2008152763A (ru) Применение агонистов каннабиноидного рецептора в качестве индуцирующих гипотермию лекарственных средств для лечения ишемии
WO1996018606A1 (en) Novel 1,3-dialkylurea derivatives
JP2013522368A5 (https=)
JP2003503449A5 (https=)
JP2004525178A5 (https=)
JP2008511597A5 (https=)
JP2005516898A5 (https=)
CA2502293A1 (en) Ship 1 modulators
JP2009532434A5 (https=)
CN1113856C (zh) 新的[(3-烷氧基苯氧基)乙基]二烷基胺衍生物及其作为局部麻醉剂的应用